CanSino Biologics Inc
SSE:688185

Watchlist Manager
CanSino Biologics Inc Logo
CanSino Biologics Inc
SSE:688185
Watchlist
Price: 67.52 CNY -4.43% Market Closed
Market Cap: 7.7B CNY
Have any thoughts about
CanSino Biologics Inc?
Write Note

CanSino Biologics Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CanSino Biologics Inc
Interest Income Expense Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
CanSino Biologics Inc
SSE:688185
Interest Income Expense
ÂĄ115.1m
CAGR 3-Years
119%
CAGR 5-Years
229%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Interest Income Expense
ÂĄ1.1B
CAGR 3-Years
52%
CAGR 5-Years
82%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Interest Income Expense
ÂĄ149.9m
CAGR 3-Years
12%
CAGR 5-Years
5%
CAGR 10-Years
20%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Interest Income Expense
ÂĄ538m
CAGR 3-Years
8%
CAGR 5-Years
5%
CAGR 10-Years
26%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Interest Income Expense
ÂĄ1.2B
CAGR 3-Years
-17%
CAGR 5-Years
-7%
CAGR 10-Years
37%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Interest Income Expense
-ÂĄ20.1m
CAGR 3-Years
-107%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is CanSino Biologics Inc's Interest Income Expense?
Interest Income Expense
115.1m CNY

Based on the financial report for Dec 31, 2023, CanSino Biologics Inc's Interest Income Expense amounts to 115.1m CNY.

What is CanSino Biologics Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
229%

Over the last year, the Interest Income Expense growth was -58%. The average annual Interest Income Expense growth rates for CanSino Biologics Inc have been 119% over the past three years , 229% over the past five years .

Back to Top